提高非诊断性支气管镜后的癌症概率估计:一项Meta分析
该Meta分析纳入46项研究共7506例患者,比较二分法与多疾病检验法在非诊断性支气管镜后估计癌症概率的准确性。结果显示,二分法持续低估癌症风险(中位差值0.12,IQR 0.06-0.23),而多疾病检验法与实际恶性率匹配。合并LR(T0)为0.46(95%CI 0.40-0.52),且与非恶性疾病患病率相关。
要点
- 非诊断性支气管镜后,二分法估计的癌症概率低于实际恶性率。
- 多疾病检验法计算的概率与实际观察到的恶性率一致。
- 合并LR(T0)为0.46,提示非诊断结果仍有一定癌症风险。
核心结论
- 传统二分法在非诊断性支气管镜后低估恶性概率,应改用多疾病检验法。
研究设计与样本
- 基于队列研究的Meta分析,纳入46项关于径向支气管内超声诊断外周肺病灶的研究,共7506例患者。
主要发现
- 在46项研究(7506例患者)中,恶性肿瘤为最终诊断的占76%,其他特定疾病占13%,非特异性纤维化或瘢痕占10%。
- 非诊断性结果患者中恶性比例与多疾病检验法计算的概率一致,而二分法持续低估癌症风险(中位差值0.12,IQR 0.06-0.23)。
- 合并LR(T0)为0.46(95%CI 0.40-0.52;I2=76%;P<.001),且与非恶性疾病患病率相关(P=.001)。
关键数值与推荐
- 多疾病检验法使用3×3列联表和似然比方法计算非诊断结果的恶性概率(LR(T0))。
- 二分法使用患病率、敏感度和特异度计算阴性预测值。
临床怎么用
- 临床医生解读支气管镜非诊断结果时,应采用多疾病检验法估计癌症概率,避免二分法低估风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with peripheral pulmonary lesions (PPLs), nondiagnostic bronchoscopy results are not uncommon. The conventional approach to estimate the probability of cancer (pCA) after bronchoscopy relies on dichotomous test assumptions, using prevalence, sensitivity, and specificity to determine negative predictive value. However, bronchoscopy is a multidisease test, raising concerns about the accuracy of dichotomous methods. RESEARCH QUESTION: By how much does calculating pCA using a dichotomous approach (pCAdichotomous) underestimate the true pCA when applied to multidisease tests like bronchoscopy for the diagnosis of PPL? METHODS: In this meta-analysis of cohort studies involving radial endobronchial ultrasound for PPL, Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were followed, constructing 2 × 2 contingency tables for calculating pCAdichotomous. For the multidisease test approach, 3 × 3 contingency tables for calculating probability of malignancy for a test that can have different categories of results and can diagnose multiple diseases (pCAmultidisease) using the likelihood ratio (LR) method for nondiagnostic results (LR(T0)) was used. Observed malignancy rates in patients with nondiagnostic results were compared with pCAdichotomous and pCAmultidisease. RESULTS: In 46 studies (7,506 patients), malignancy was the underlying diagnosis in 76% of cases, another specific disease in 13% of cases, and nonspecific fibrosis or scar in 10% of cases. The percentage of patients with nondiagnostic results who had malignancy matched pCAmultidisease across all studies. In contrast, pCAdichotomous consistently underestimated cancer risk (median difference, 0.12; interquartile range, 0.06-0.23), particularly in studies with a higher prevalence of nonmalignant disease. The pooled LR(T0) was 0.46 (95% CI, 0.40-0.52; I2 = 76%; P < .001) and correlated with the prevalence of nonmalignant diseases (P = .001). INTERPRETATION: Conventional dichotomous methods for estimating pCA after nondiagnostic bronchoscopies underestimate the likelihood of malignancy. Physicians should opt for the multidisease test approach when interpreting bronchoscopy results.
引用
- Sainz PV, Grosu HB, Shojaee S, et al. Improving Cancer Probability Estimation in Nondiagnostic Bronchoscopies: A Meta-Analysis. Chest. 2024. PMID: 39059579. doi:10.1016/j.chest.2024.07.138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。